271 related articles for article (PubMed ID: 28752891)
1. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
2. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/beta-catenin signalling in mesoderm development.
Liu F; van den Broek O; Destrée O; Hoppler S
Development; 2005 Dec; 132(24):5375-85. PubMed ID: 16291789
[TBL] [Abstract][Full Text] [Related]
4. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
5. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
Mi K; Johnson GV
J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
[TBL] [Abstract][Full Text] [Related]
6. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.
Zimmerli D; Hausmann G; Cantù C; Basler K
Br J Pharmacol; 2017 Dec; 174(24):4600-4610. PubMed ID: 28521071
[TBL] [Abstract][Full Text] [Related]
8. Molecular regulation and pharmacological targeting of the β-catenin destruction complex.
van Kappel EC; Maurice MM
Br J Pharmacol; 2017 Dec; 174(24):4575-4588. PubMed ID: 28634996
[TBL] [Abstract][Full Text] [Related]
9. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
10. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.
Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK
J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246
[TBL] [Abstract][Full Text] [Related]
11. Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.
DeBruine ZJ; Xu HE; Melcher K
Br J Pharmacol; 2017 Dec; 174(24):4564-4574. PubMed ID: 28941231
[TBL] [Abstract][Full Text] [Related]
12. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
Waterman ML
Cancer Metastasis Rev; 2004; 23(1-2):41-52. PubMed ID: 15000148
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling inside the nucleus.
Shitashige M; Hirohashi S; Yamada T
Cancer Sci; 2008 Apr; 99(4):631-7. PubMed ID: 18177486
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
16. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.
Jeong YH; Sekiya M; Hirata M; Ye M; Yamagishi A; Lee SM; Kang MJ; Hosoda A; Fukumura T; Kim DH; Saeki S
Biochem Biophys Res Commun; 2010 Feb; 392(4):495-9. PubMed ID: 20093106
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway.
Lu FI; Sun YH; Wei CY; Thisse C; Thisse B
Nat Commun; 2014 Nov; 5():5368. PubMed ID: 25371059
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
20. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function.
Townsley FM; Cliffe A; Bienz M
Nat Cell Biol; 2004 Jul; 6(7):626-33. PubMed ID: 15208637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]